Lilly launches smallest single-dose vials of Zepbound for $399

Eli Lilly (LLY.N) said it has begun selling vials of the smallest, starter dose of its popular weight-loss drug Zepbound in the United States for $399 for a month on its direct-to-consumer website to try to increase supplies in the marketplace.